Form 8-K - Current report:
SEC Accession No. 0001829126-24-005654
Filing Date
2024-08-19
Accepted
2024-08-19 16:15:30
Documents
13
Period of Report
2024-08-14
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 30918
  Complete submission text file 0001829126-24-005654.txt   204452

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE opgn-20240814.xsd EX-101.SCH 3006
3 XBRL LABEL FILE opgn-20240814_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE opgn-20240814_pre.xml EX-101.PRE 22353
15 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3650
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 241220729
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)